These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
169 related articles for article (PubMed ID: 39267943)
21. The unfinished agenda of communicable diseases among children and adolescents before the COVID-19 pandemic, 1990-2019: a systematic analysis of the Global Burden of Disease Study 2019. GBD 2019 Child and Adolescent Communicable Disease Collaborators Lancet; 2023 Jul; 402(10398):313-335. PubMed ID: 37393924 [TBL] [Abstract][Full Text] [Related]
22. Burden of disease scenarios for 204 countries and territories, 2022-2050: a forecasting analysis for the Global Burden of Disease Study 2021. GBD 2021 Forecasting Collaborators Lancet; 2024 May; 403(10440):2204-2256. PubMed ID: 38762325 [TBL] [Abstract][Full Text] [Related]
23. Disability adjusted life years associated with COVID-19 in Denmark in the first year of the pandemic. Pires SM; Redondo HG; Espenhain L; Jakobsen LS; Legarth R; Meaidi M; Koch A; Tribler S; Martin-Bertelsen T; Ethelberg S BMC Public Health; 2022 Jul; 22(1):1315. PubMed ID: 35804310 [TBL] [Abstract][Full Text] [Related]
24. Trends in Nationally Notifiable Infectious Diseases in Humans and Animals during COVID-19 Pandemic, South Korea. Chang T; Cho SI; Yoo DS; Min KD Emerg Infect Dis; 2024 Jun; 30(6):1154-1163. PubMed ID: 38781924 [TBL] [Abstract][Full Text] [Related]
25. Global burden of 288 causes of death and life expectancy decomposition in 204 countries and territories and 811 subnational locations, 1990-2021: a systematic analysis for the Global Burden of Disease Study 2021. GBD 2021 Causes of Death Collaborators Lancet; 2024 May; 403(10440):2100-2132. PubMed ID: 38582094 [TBL] [Abstract][Full Text] [Related]
26. Comparison of Disability-Adjusted Life Years (DALYs) and Economic Burden on People With Drug-Susceptible Tuberculosis and Multidrug-Resistant Tuberculosis in Korea. Lee S; Kim MJ; Lee SH; Kim HY; Kim HS; Oh IH Front Public Health; 2022; 10():848370. PubMed ID: 35480575 [TBL] [Abstract][Full Text] [Related]
27. Global burden of 369 diseases and injuries in 204 countries and territories, 1990-2019: a systematic analysis for the Global Burden of Disease Study 2019. GBD 2019 Diseases and Injuries Collaborators Lancet; 2020 Oct; 396(10258):1204-1222. PubMed ID: 33069326 [TBL] [Abstract][Full Text] [Related]
28. Impact of infectious diseases on population health using incidence-based disability-adjusted life years (DALYs): results from the Burden of Communicable Diseases in Europe study, European Union and European Economic Area countries, 2009 to 2013. Cassini A; Colzani E; Pini A; Mangen MJ; Plass D; McDonald SA; Maringhini G; van Lier A; Haagsma JA; Havelaar AH; Kramarz P; Kretzschmar ME; Euro Surveill; 2018 Apr; 23(16):. PubMed ID: 29692315 [TBL] [Abstract][Full Text] [Related]
29. Clinical effects of non-pharmaceutical interventions for COVID-19 on other nationally notifiable infectious diseases in South Korea. Lee HJ; Hwang BS; Im SH; Mun SK; Chang M Korean J Intern Med; 2024 Sep; 39(5):823-832. PubMed ID: 39135523 [TBL] [Abstract][Full Text] [Related]
30. Global, regional, and national disability-adjusted life-years (DALYs) for 359 diseases and injuries and healthy life expectancy (HALE) for 195 countries and territories, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017. GBD 2017 DALYs and HALE Collaborators Lancet; 2018 Nov; 392(10159):1859-1922. PubMed ID: 30415748 [TBL] [Abstract][Full Text] [Related]
31. Disability-Adjusted Life Years for Communicable Disease in the Korean Burden of Disease Study 2012. Lee YR; Moon K; Kim YA; Park SY; Oh CM; Lee KS; Oh IH J Korean Med Sci; 2016 Nov; 31 Suppl 2(Suppl 2):S178-S183. PubMed ID: 27775255 [TBL] [Abstract][Full Text] [Related]
32. Relative Burdens of the COVID-19, Malaria, Tuberculosis, and HIV/AIDS Epidemics in Sub-Saharan Africa. Bell D; Schultz Hansen K Am J Trop Med Hyg; 2021 Oct; 105(6):1510-1515. PubMed ID: 34634773 [TBL] [Abstract][Full Text] [Related]
33. Global burden of disease attributable to mental and substance use disorders: findings from the Global Burden of Disease Study 2010. Whiteford HA; Degenhardt L; Rehm J; Baxter AJ; Ferrari AJ; Erskine HE; Charlson FJ; Norman RE; Flaxman AD; Johns N; Burstein R; Murray CJ; Vos T Lancet; 2013 Nov; 382(9904):1575-86. PubMed ID: 23993280 [TBL] [Abstract][Full Text] [Related]
34. The health impact of long COVID during the 2021-2022 Omicron wave in Australia: a quantitative burden of disease study. Howe S; Szanyi J; Blakely T Int J Epidemiol; 2023 Jun; 52(3):677-689. PubMed ID: 37011639 [TBL] [Abstract][Full Text] [Related]
35. Differentiating impacts of non-pharmaceutical interventions on non-coronavirus disease-2019 respiratory viral infections: Hospital-based retrospective observational study in Taiwan. Chen AP; Chu IY; Yeh ML; Chen YY; Lee CL; Lin HH; Chan YJ; Chen HP Influenza Other Respir Viruses; 2021 Jul; 15(4):478-487. PubMed ID: 33825310 [TBL] [Abstract][Full Text] [Related]
36. The Outcome and Implications of Public Precautionary Measures in Taiwan-Declining Respiratory Disease Cases in the COVID-19 Pandemic. Hsieh CC; Lin CH; Wang WYC; Pauleen DJ; Chen JV Int J Environ Res Public Health; 2020 Jul; 17(13):. PubMed ID: 32640752 [TBL] [Abstract][Full Text] [Related]
37. Impact of twelve immunization-preventable infectious diseases on population health using disability-adjusted life years (DALYs) in Spain. Pérez-Rubio A; Mestre-Ferrandiz J; López-Belmonte JL; Diaz-Aguiló A; Lorenzo-Herrero S; Crespo C BMC Infect Dis; 2024 Aug; 24(1):779. PubMed ID: 39103777 [TBL] [Abstract][Full Text] [Related]
38. The burden of Neglected Tropical Diseases in Brazil, 1990-2016: A subnational analysis from the Global Burden of Disease Study 2016. Martins-Melo FR; Carneiro M; Ramos AN; Heukelbach J; Ribeiro ALP; Werneck GL PLoS Negl Trop Dis; 2018 Jun; 12(6):e0006559. PubMed ID: 29864133 [TBL] [Abstract][Full Text] [Related]
39. The state of health in the Arab world, 1990-2010: an analysis of the burden of diseases, injuries, and risk factors. Mokdad AH; Jaber S; Aziz MI; AlBuhairan F; AlGhaithi A; AlHamad NM; Al-Hooti SN; Al-Jasari A; AlMazroa MA; AlQasmi AM; Alsowaidi S; Asad M; Atkinson C; Badawi A; Bakfalouni T; Barkia A; Biryukov S; El Bcheraoui C; Daoud F; Forouzanfar MH; Gonzalez-Medina D; Hamadeh RR; Hsairi M; Hussein SS; Karam N; Khalifa SE; Khoja TA; Lami F; Leach-Kemon K; Memish ZA; Mokdad AA; Naghavi M; Nasher J; Qasem MB; Shuaib M; Al Thani AA; Al Thani MH; Zamakhshary M; Lopez AD; Murray CJ Lancet; 2014 Jan; 383(9914):309-20. PubMed ID: 24452042 [TBL] [Abstract][Full Text] [Related]
40. Measuring the COVID-19 Mortality Burden in the United States : A Microsimulation Study. Reif J; Heun-Johnson H; Tysinger B; Lakdawalla D Ann Intern Med; 2021 Dec; 174(12):1700-1709. PubMed ID: 34543588 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]